Listed

Journey Medical Corp: Form 10-Q for the period ended Jun 30, 2022

Filed with the SEC on Aug 9, 2022 and accepted by EDGAR at Aug 9, 2022, 17:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-04-01 to 2022-06-30$18.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2022-01-01 to 2022-06-30$39.0mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-04-01 to 2022-06-30$7.6mus-gaap:CostOfRevenue
Cost of revenue6 months2022-01-01 to 2022-06-30$15.8mus-gaap:CostOfRevenue
Research and development3 months2022-04-01 to 2022-06-30$2.6mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2022-01-01 to 2022-06-30$3.9mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2022-04-01 to 2022-06-30$15.2mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2022-01-01 to 2022-06-30$29.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-04-01 to 2022-06-30−$7.1mus-gaap:OperatingIncomeLoss
Operating income6 months2022-01-01 to 2022-06-30−$8.0mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-04-01 to 2022-06-30$454.0kus-gaap:InterestExpense
Interest expense6 months2022-01-01 to 2022-06-30$843.0kus-gaap:InterestExpense
Income tax3 months2022-04-01 to 2022-06-30−$64.0kus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2022-01-01 to 2022-06-30$40.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-04-01 to 2022-06-30−$7.5mus-gaap:NetIncomeLoss
Net income6 months2022-01-01 to 2022-06-30−$8.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2022-04-01 to 2022-06-30−$0.43us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2022-01-01 to 2022-06-30−$0.51us-gaap:EarningsPerShareDiluted
Basic EPS3 months2022-04-01 to 2022-06-30−$0.43us-gaap:EarningsPerShareBasic
Basic EPS6 months2022-01-01 to 2022-06-30−$0.51us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2022-04-01 to 2022-06-3017,455,894 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2022-01-01 to 2022-06-3017,386,538 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2022-01-01 to 2022-06-30−$2.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Cash and equivalentsAt period end2022-06-30$38.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-06-30$83.9mus-gaap:AssetsCurrent
Total assetsAt period end2022-06-30$113.5mus-gaap:Assets
Current liabilitiesAt period end2022-06-30$60.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-06-30$78.7mus-gaap:Liabilities
Long-term debtAt period end2022-06-30$14.8mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2022-06-30$34.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001410578-22-002183. Last ingested by Listed: Nov 13, 2026, 16:22 ET. Listed shows no prices and gives no investment advice.